Virtual Clinical Trials: Perspectives in Dermatology

Area of Science:

• Clinical Research
• Digital Health
• Dermatology

Background:

• Drug development costs are high, with clinical trials comprising over two-thirds of expenses.
• Patient recruitment and retention are major hurdles, causing significant delays and revenue loss.
• Virtual clinical trials (VCT) emerge as a solution, utilizing remote technology to address these challenges.

Purpose of the Study:

• To describe virtual clinical trials (VCT) and their specific applications and benefits in dermatological research.
• To highlight how VCT overcome traditional clinical trial limitations like patient recruitment and engagement.

Main Methods:

• VCT utilize technology such as apps and monitoring devices for remote patient participation.
• Web platforms facilitate recruitment, informed consent, counseling, and endpoint measurement.
• Patients remain home-based throughout the trial process.

Main Results:

• Studies confirm VCT are operationally feasible and successful.
• VCT demonstrate higher recruitment rates, improved compliance, and lower drop-out rates compared to traditional trials.
• Trials conducted via VCT are completed faster.

Conclusions:

• VCT are well-suited for dermatology due to the visual nature of skin conditions and ease of virtual assessment.
• The remote, technology-driven approach of VCT aligns with dermatologists' routine diagnostic methods.
• VCT offer a promising, efficient, and effective model for advancing dermatological research.